Sara J. Bonvini - Concepedia

Author

Sara J. Bonvini

Also Known As

Bonvini, Sara, S Bonvini, S.J. Bonvini, Sara Bonvini, Sara J Bonvini, Sara J. Bonvini, Sara Jane Bonvini, Sara J. Bonvini

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Imperial College London University of Manchester AstraZeneca (Sweden)Asthma UK Pfizer (United Kingdom)

About

Sara J. Bonvini is an author at Imperial College London specializing in medicine, pharmacology, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	57
2	Pharmacology	2	2	57
3	Public Health	1	1	21
4	Allergy	1	1	36
5	Pulmonary Disease	1	1	36

Sara J. Bonvini

Publications

656

Citations

H-Index

Page 1

	Year	Citations
Neurophenotypes in Airway Diseases. Insights from Translational Cough Studies Maria G. Belvisi, Mark A. Birrell, Saifudin Khalid, American Journal of Respiratory and Critical Care Medicine	2016	123
Transient receptor potential cation channel, subfamily V, member 4 and airway sensory afferent activation: Role of adenosine triphosphate Sara J. Bonvini, Mark A. Birrell, Megan S. Grace, Journal of Allergy and Clinical Immunology	2016	121
Mechanistic link between diesel exhaust particles and respiratory reflexes Ryan Karis Robinson, Mark A. Birrell, John J. Adcock, Journal of Allergy and Clinical Immunology	2017	113
Tiotropium modulates transient receptor potential V1 (TRPV1) in airway sensory nerves: A beneficial off-target effect?⋆ Mark A. Birrell, Sara J. Bonvini, Eric Dubuis, Journal of Allergy and Clinical Immunology	2014	75
Novel airway smooth muscle–mast cell interactions and a role for the TRPV4-ATP axis in non-atopic asthma Sara J. Bonvini, Mark A. Birrell, Eric Dubuis, European Respiratory Journal	2020	57
Prostaglandin D<sub>2</sub>and the role of the DP<sub>1</sub>, DP<sub>2</sub>and TP receptors in the control of airway reflex events Sarah A. Maher, Mark A. Birrell, John J. Adcock, European Respiratory Journal	2014	51
Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models Katie Baker, Sara J. Bonvini, Chantal Donovan, Pulmonary Pharmacology & Therapeutics AsthmaVivo ModelsDrug TargetDrug TargetingAllergy	2014	36
Selectivity profiling of the novel EP<sub>2</sub> receptor antagonist, PF‐04418948, in functional bioassay systems: atypical affinity at the guinea pig EP<sub>2</sub> receptor Mark A. Birrell, Sarah A. Maher, James Buckley, British Journal of Pharmacology	2012	30
The Peroxisome Proliferator–Activated Receptor β/δ Agonist GW0742 has Direct Protective Effects on Right Heart Hypertrophy Baktybek Kojonazarov, Himal Luitel, Akylbek Sydykov, Pulmonary Circulation Heart FailureLung InflammationCardiovascular PharmacologyPulmonary HypertensionCardiovascular Function	2013	21
Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy Michael A. Wortley, John J. Adcock, Eric Dubuis, European Respiratory Journal	2017	18

Page 1